MX2018000239A - Bifosfonatos de hbed, sus conjugados radio metalicos y su uso como agentes teranosticos. - Google Patents
Bifosfonatos de hbed, sus conjugados radio metalicos y su uso como agentes teranosticos.Info
- Publication number
- MX2018000239A MX2018000239A MX2018000239A MX2018000239A MX2018000239A MX 2018000239 A MX2018000239 A MX 2018000239A MX 2018000239 A MX2018000239 A MX 2018000239A MX 2018000239 A MX2018000239 A MX 2018000239A MX 2018000239 A MX2018000239 A MX 2018000239A
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- agents
- bifosphonates
- teranostic
- hbed
- Prior art date
Links
- GRUVVLWKPGIYEG-UHFFFAOYSA-N 2-[2-[carboxymethyl-[(2-hydroxyphenyl)methyl]amino]ethyl-[(2-hydroxyphenyl)methyl]amino]acetic acid Chemical compound C=1C=CC=C(O)C=1CN(CC(=O)O)CCN(CC(O)=O)CC1=CC=CC=C1O GRUVVLWKPGIYEG-UHFFFAOYSA-N 0.000 title 1
- 239000002184 metal Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000012216 imaging agent Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Radiology & Medical Imaging (AREA)
Abstract
La presente invención se refiere a compuestos de acuerdo con la formula I o formula II que son agentes de toma de imágenes óseas potenciales; ciertos compuestos etiquetados con 68Ga mostraron excelente captación y retención ósea; la presente invención también se refiere a composiciones farmacéuticas que comprenden un portador farmacéuticamente aceptable y un compuesto de formula I o formula II o una sal farmacéuticamente aceptable del mismo.(ver formula I y formula II).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562189652P | 2015-07-07 | 2015-07-07 | |
US201662320296P | 2016-04-08 | 2016-04-08 | |
PCT/US2016/041040 WO2017007790A1 (en) | 2015-07-07 | 2016-07-06 | Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2018000239A true MX2018000239A (es) | 2018-05-23 |
MX377208B MX377208B (es) | 2025-03-07 |
Family
ID=57685907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018000239A MX377208B (es) | 2015-07-07 | 2016-07-06 | Bifosfonatos de hbed, sus conjugados radio metalicos y su uso como agentes teranosticos. |
Country Status (12)
Country | Link |
---|---|
US (1) | US10253052B2 (es) |
EP (1) | EP3319643B1 (es) |
JP (1) | JP6792875B2 (es) |
KR (1) | KR102651945B1 (es) |
CN (1) | CN107847618B (es) |
AU (1) | AU2016289474C1 (es) |
CA (1) | CA2991498A1 (es) |
DK (1) | DK3319643T3 (es) |
EA (1) | EA201890221A1 (es) |
IL (1) | IL256726A (es) |
MX (1) | MX377208B (es) |
WO (1) | WO2017007790A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX377208B (es) | 2015-07-07 | 2025-03-07 | Five Eleven Pharma Inc | Bifosfonatos de hbed, sus conjugados radio metalicos y su uso como agentes teranosticos. |
TW201832750A (zh) * | 2017-03-02 | 2018-09-16 | 美商511製藥公司 | 放射性藥品標記裝置 |
US11723992B2 (en) * | 2018-08-03 | 2023-08-15 | Board Of Regents, The University Of Texas System | Method for extraction and purification of 68GA |
CN109438517B (zh) * | 2018-12-27 | 2021-01-08 | 北京久杰净化工程技术有限公司 | 一种与羰基金属核心配位的双功能连接剂的配合物及其制备方法 |
KR20220004125A (ko) * | 2019-04-26 | 2022-01-11 | 파이브 일레븐 파마 인크. | 진단제 및 방사성핵종 치료제로서의 전립선-특이적 막 항원 (psma) 억제제 |
US20230001027A1 (en) * | 2019-10-01 | 2023-01-05 | City Of Hope | Metal chelating agents and methods of using the same |
DE102022105175A1 (de) * | 2022-03-04 | 2023-09-07 | Atoms for Cure GmbH | Markierungsvorläufer und Radiotracer mit drei oder mehr Targeting-Vektoren für die nuklearmedizinische Theranostik |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE329623T1 (de) * | 2001-10-22 | 2006-07-15 | Dow Global Technologies Inc | Radiopharmazeutishes mittel zur behandlung von krebs im frühstadium |
JP2006523237A (ja) * | 2003-04-03 | 2006-10-12 | セマフォア ファーマシューティカルズ, インコーポレイテッド | Pi−3キナーゼインヒビタープロドラッグ |
US7161000B2 (en) * | 2003-05-30 | 2007-01-09 | Sumitomo Chemical Company, Limited | Method for producing phenol condensate |
US10925977B2 (en) * | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
CN104774175B (zh) * | 2007-06-26 | 2019-04-16 | 约翰·霍普金斯大学 | 标记的前列腺特异性膜抗原(psma)的抑制子、生物学评估及作为成像试剂的用途 |
US20120148492A1 (en) * | 2009-08-20 | 2012-06-14 | Fujifilm Ri Pharma Co., Ltd. | Bisphosphonic acid derivative and compound thereof labeled with radioactive metal nuclide |
EP2697347B1 (en) * | 2011-04-13 | 2016-11-16 | Firmenich SA | Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones |
ITMI20121156A1 (it) | 2012-06-29 | 2013-12-30 | Consiglio Nazionale Ricerche | Metodo di elaborazione di immagini di tomografia a coerenza ottica |
EP2862857A1 (en) * | 2013-10-18 | 2015-04-22 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
MX377208B (es) | 2015-07-07 | 2025-03-07 | Five Eleven Pharma Inc | Bifosfonatos de hbed, sus conjugados radio metalicos y su uso como agentes teranosticos. |
-
2016
- 2016-07-06 MX MX2018000239A patent/MX377208B/es active IP Right Grant
- 2016-07-06 EP EP16821892.3A patent/EP3319643B1/en active Active
- 2016-07-06 EA EA201890221A patent/EA201890221A1/ru unknown
- 2016-07-06 CN CN201680046397.5A patent/CN107847618B/zh active Active
- 2016-07-06 WO PCT/US2016/041040 patent/WO2017007790A1/en active Application Filing
- 2016-07-06 JP JP2017568376A patent/JP6792875B2/ja active Active
- 2016-07-06 AU AU2016289474A patent/AU2016289474C1/en active Active
- 2016-07-06 KR KR1020187002872A patent/KR102651945B1/ko active Active
- 2016-07-06 CA CA2991498A patent/CA2991498A1/en active Pending
- 2016-07-06 US US15/203,602 patent/US10253052B2/en active Active
- 2016-07-06 DK DK16821892.3T patent/DK3319643T3/da active
-
2018
- 2018-01-03 IL IL256726A patent/IL256726A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US10253052B2 (en) | 2019-04-09 |
AU2016289474B2 (en) | 2020-12-24 |
AU2016289474C1 (en) | 2021-04-08 |
CN107847618A (zh) | 2018-03-27 |
AU2016289474A1 (en) | 2018-02-01 |
JP2018524352A (ja) | 2018-08-30 |
IL256726A (en) | 2018-03-29 |
KR20180026736A (ko) | 2018-03-13 |
WO2017007790A1 (en) | 2017-01-12 |
HK1254864A1 (en) | 2019-07-26 |
EP3319643A1 (en) | 2018-05-16 |
CA2991498A1 (en) | 2017-01-12 |
DK3319643T3 (da) | 2020-06-15 |
EP3319643B1 (en) | 2020-04-22 |
CN107847618B (zh) | 2021-07-16 |
JP6792875B2 (ja) | 2020-12-02 |
MX377208B (es) | 2025-03-07 |
US20170022224A1 (en) | 2017-01-26 |
KR102651945B1 (ko) | 2024-03-26 |
WO2017007790A9 (en) | 2018-01-04 |
EA201890221A1 (ru) | 2018-06-29 |
EP3319643A4 (en) | 2019-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018000239A (es) | Bifosfonatos de hbed, sus conjugados radio metalicos y su uso como agentes teranosticos. | |
CL2023001909A1 (es) | Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo | |
ZA201906832B (en) | Novel psma-binding agents and uses thereof | |
MX375570B (es) | Conjugados de pirrolobenzodiazepina | |
EA201692002A1 (ru) | Стабильные составы для антител к cd19 и конъюгатов антитело-лекарственное средство | |
EA201891083A1 (ru) | Составы антител к cd38 для подкожного введения и их применение | |
MA39362A1 (fr) | Compositions stables d'iode non complexé et procédés d'utilisation. | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
PH12017501539A1 (en) | Disacetoxytubulysin h and analogs thereof | |
CL2016003422A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
CY1124425T1 (el) | Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης | |
EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
CL2016003423A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
MX2017005199A (es) | Conjugados y reactivos de conjugacion. | |
MX376122B (es) | Composiciones de plinabulina. | |
EA201890898A1 (ru) | Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение | |
CL2017002856A1 (es) | Compuestos de tioéter como inhibidores de la nitrificación | |
CU20170012A7 (es) | Anticuerpos anti proteína similar a angiopoyetina 4 | |
SV2019005838A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
MX394833B (es) | Formulaciones con mejora de la estabilidad. | |
EA201591717A1 (ru) | Твердые формы гидрохлорида вемурафениба | |
AU2016356504A8 (en) | 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential | |
MX2016003725A (es) | Compuestos y su uso para la preparacion de agentes de formacion de imagen tau y formulaciones para la formacion de imagen tau. | |
MX386402B (es) | Tratamiento con trastuzumab vc-seco-duba de pacientes de cáncer refractarios a trastuzumab emtansina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |